Close
Achema

Drug Research

New Drug Mix From ICR And The Royal Marsden...

The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by the...

Citius Pharma selects global CRO, Biorasi to help expand...

Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company, announced that it has selected Biorasi, LLC (Biorasi), a global clinical research organization (CRO), to help expand the...

Oragenics Engages KBI Biopharma to Support Development of Intranasal...

Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization and cGMP manufacturing of the Company’s...

WuXi ATU Announces Launch of TESSA Technology to Improve...

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSAâ„¢). This technology is a state-of-the-art...

Midatech Pharma PLC Announces R&D Collaboration with Janssen on...

Midatech Pharma PLC, a drug delivery technology company, announced an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21...

Vibalogics Completes Major Milestone in $50M Cuxhaven Facility Expansion...

Vibalogics, a leading virotherapy contract development and manufacturing organization (CDMO) focused on the production of live– viruses and viral vectors, has announced the completion of...

Orbit Discovery and WuXi AppTec sign agreement to access...

Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read